Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance study.

Nozawa T, Iwata N, Igarashi T, Kobayashi I, Ota S, Yamada T, Bando E, Habiro K, Takei S.

Open source

DOI
10.1186/s12969-025-01069-4
Published
2025-02-19
Container
Pediatr Rheumatol Online J
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12969-025-01069-4,
  title = {Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance study.},
  author = {Nozawa T and  Iwata N and  Igarashi T and  Kobayashi I and  Ota S and  Yamada T and  Bando E and  Habiro K and  Takei S.},
  year = {2025},
  journal = {Pediatr Rheumatol Online J},
  doi = {10.1186/s12969-025-01069-4},
  url = {https://doi.org/10.1186/s12969-025-01069-4}
}

RIS

TY  - JOUR
TI  - Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance study.
AU  - Nozawa T
AU  -  Iwata N
AU  -  Igarashi T
AU  -  Kobayashi I
AU  -  Ota S
AU  -  Yamada T
AU  -  Bando E
AU  -  Habiro K
AU  -  Takei S.
PY  - 2025
JO  - Pediatr Rheumatol Online J
DO  - 10.1186/s12969-025-01069-4
UR  - https://doi.org/10.1186/s12969-025-01069-4
ER  - 

APA

T, N., N, I., T, I., I, K., S, O., T, Y., E, B., K, H., & S., T. (2025). Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance study.. Pediatr Rheumatol Online J. https://doi.org/10.1186/s12969-025-01069-4

Source records